SCHEMBL6709039

SCHEMBL6709039

CCN(CC)S(=O)(=O)c1ccc2onc(C(=O)Nc3ccc(C#N)cc3-c3noc(=O)[nH]3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 2/20 0.42
RXFP1 Q9HBX9 5/20 0.40
HPGD P15428 3/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 2/20 0.38
PKM P14618 1/20 0.38
GAA P10253 2/20 0.37
USP2 O75604 1/20 0.36
BRD4 O60885 1/20 0.36
BRPF1 P55201 1/20 0.36
CRHBP P24387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710040 0.91 CSF1R (0.38) ALDH1A1SMN1; SMN2LMNAPOLBKMT2A
SCHEMBL6711925 0.88 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAPOLBRXFP1
SCHEMBL6707839 0.88 RXFP1 (0.49) ALDH1A1SMN1; SMN2LMNAPOLBRXFP1
SCHEMBL6708970 0.87 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNAPOLBRXFP1
SCHEMBL6708774 0.83 GPR27 (0.43) PKMBRD4
SCHEMBL6710163 0.83 HIF1A (0.43) POLBMAPTTP53
SCHEMBL6818893 0.83 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2LMNAPOLBRXFP1
SCHEMBL6708048 0.83 TNIK (0.36) POLBMAPTTP53
SCHEMBL6707767 0.82 HIF1A (0.42) ALDH1A1SMN1; SMN2LMNAKMT2AMEN1
SCHEMBL6707723 0.82 GRIK1 (0.39) ALDH1A1SMN1; SMN2POLBHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885SMN1; SMN2 2635/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.